Whalesbook
📉 The Financial Deep Dive
Sastasundar Ventures Limited has revealed its Q3 FY26 financial results, highlighting a marked divergence between its consolidated and standalone operational performances. The consolidated segment experienced a significant profit turnaround, while the standalone business grappled with ongoing losses.
Consolidated Performance: A Turnaround Story
The consolidated results for the quarter ended December 31, 2025 (Q3 FY26) demonstrated a strong recovery. Revenue from operations surged by an impressive 22.9% year-on-year (YoY) to ₹34,573.70 Lakhs, up from ₹28,129.05 Lakhs in Q3 FY25. Total income grew 31.1% YoY to ₹35,335.33 Lakhs, with total expenses rising 16.9% YoY to ₹35,843.46 Lakhs. Crucially, the company flipped to a positive Profit Before Tax (PBT) of ₹91.87 Lakhs, a substantial improvement from a loss of ₹3,924.19 Lakhs in the prior year period. This translated into a Net Profit after tax of ₹35.87 Lakhs, a dramatic shift from a net loss of ₹3,719.18 Lakhs in Q3 FY25. Consequently, Basic and Diluted Earnings Per Share (EPS) improved to ₹0.35 from (₹3.39).
The nine-month period (9MFY26) also reflected this positive trend, with consolidated revenue rising 14.6% YoY to ₹94,548.58 Lakhs. The company achieved a PBT of ₹1,153.41 Lakhs, a significant turnaround from a loss of ₹18,822.64 Lakhs in 9MFY25, leading to a Net Profit of ₹1,151.15 Lakhs for the period. EPS stood at ₹0.35 compared to a loss of (₹18.66) in the previous year.
Standalone Performance: Facing Headwinds
In contrast, standalone operations for Q3 FY26 showed a modest revenue increase of 13.4% YoY to ₹10.72 Lakhs. Total income saw a substantial jump to ₹30.17 Lakhs from ₹10.59 Lakhs YoY, while total expenses decreased by 21.1% YoY to ₹40.66 Lakhs. This led to the net loss for the quarter narrowing to ₹10.49 Lakhs from ₹40.99 Lakhs, improving EPS to (₹0.03) from (₹0.13). However, for the nine-month period (9MFY26), standalone revenue declined 3.9% YoY to ₹28.91 Lakhs, and the net loss widened to ₹79.92 Lakhs from ₹64.54 Lakhs.
Key Events Impacting Results
Several strategic moves at the subsidiary level significantly influenced the consolidated outcomes. Sastasundar Healthbuddy Limited (SHBL), a material subsidiary, completed a buy-back of equity shares worth ₹10,000.00 Lakhs, bolstering Sastasundar Ventures' shareholding from 72.14% to 78.89%. The disposal of subsidiary Happymate Foods Limited was completed. The investment in associate Flipkart Health Limited was liquidated on October 29, 2024.
Exceptional Items and Concerns
Consolidated results included an additional impairment loss of ₹16.61 Lakhs for Genu Path Labs in 9MFY26. Sastasundar Healthbuddy Limited recovered ₹128.00 Lakhs, recognized as income. A significant previous year loss of ₹19,118.54 Lakhs on the liquidation of investment in Flipchart Health Limited was also a factor in prior period comparisons.
A key red flag is Genu Path Labs Limited, a step-down subsidiary, which continues to report operational losses. A material uncertainty related to its going concern status has been noted, and it has filed a petition with the NCLT for share capital reduction.
🚩 Risks & Outlook
- Specific Risks: The primary risks revolve around the sustainability of the consolidated turnaround and the continued underperformance of standalone operations. The going concern issue with Genu Path Labs requires close monitoring. The absence of any forward-looking guidance from management leaves the future trajectory uncertain.
- The Forward View: Investors will be keen to observe if the consolidated profitability can be sustained and if there are any plans to revive the standalone business. The resolution of Genu Path Labs' situation and any potential impact on consolidated financials will be critical watch points in the coming quarters.